The situation in Germany
A new law released March 10 2017 in Germany changed narcotics regulation drastically. It allows to provide medical cannabis to patients requiring treatment directly by doctors.
Deutsche Medizinalcannabis GmbH is a German cannabis company founded to bring the highest quality medical cannabis products to Germany and Europe. The company is driven by patient needs and works closely with doctors and pharmacists to secure and maintain the quality of all imported product.
At the same time, its cooperation with licensed producers from around the world provides the basis to ensure a steady and reliable supply of medical cannabis.
Medical cannabis offers, partly due to its main component, Δ9-trans-tetrahydrocannabinol, but also many other effective compounds, the potential for a natural remedy for up to 240 000 patients in Germany.
The experienced management team together with a distribution network that reaches 20,000 pharmacies in Germany will allow DMC Pharma to become the leading importer and wholesaler of medical cannabis products in Germany.
Europa changes with us
Not only Germany, but many other countries in Europe have realized the great potential that cannabis offers as a medical product.
In every country that has provided patient access to cannabis, the patient numbers have risen substantially over the past few years.
We want to help supply cannabis to every european country that decides to provide its citizens with access to modern cannabis therapies.